Journal of Thyroid Cancer · Submit a Manuscript
Submit a Manuscript
One route, one editorial office. This page covers what to prepare, where to send it and what happens afterwards.
01 · Fit
Before you start
Two questions decide whether a submission is worth preparing, and both are answerable in a few minutes.
Is the manuscript in scope?
The manuscript should connect its material, methods, and conclusions to a substantive thyroid-oncology question, including cancer risk, the benign–malignant diagnostic boundary, tumor biology, care, or outcomes. The Aims and Scope page describes the journal’s research areas and fit guidance.
Is it ready?
Manuscripts undergo initial editorial screening for scope, scientific and reporting quality, ethics, and completeness. Prepare the files and declarations appropriate to the study design before submission.
02 · Files
What to prepare
- Manuscript file. Word or LaTeX, double-spaced, with continuous line numbers.
- Title page. Title, all authors with affiliations, ORCID iDs, and the corresponding author’s contact details. Supplied as a separate file so the manuscript can be sent for double-blind review if requested.
- Structured abstract. Under 300 words, with objectives, methods, results and conclusions.
- Keywords. Terms reflecting the thyroid cancer subtype, the discipline and the methods used.
- Figures. High resolution, 300 DPI minimum, cited in order, each with a descriptive caption. Units and abbreviations defined.
- Tables. Editable rather than images, cited in order, each with a caption.
- Supplementary files. Cited in the manuscript and labeled so each can be identified on its own.
- Reporting checklist. The completed checklist for the study design — CONSORT, STROBE, PRISMA or CARE as applicable.
- Cover letter. What the study adds and why it belongs in this journal. If submitting to an open special issue, name it here.
03 · Declarations
What must be declared
These are conditions of publication and are checked at screening. A manuscript missing any of them is returned before review rather than after it.
- Ethics approval. The approving committee or review board, and the approval reference where one is issued. Studies exempt from review state the basis.
- Informed consent. The consent obtained. Case reports and clinical images require documented consent to publish.
- Patient privacy. Confirmation that identifying details have been removed unless essential and consented.
- Trial registration. For interventional trials: registry, registration number and date.
- Data availability. Where the data are, or why they cannot be shared.
- Funding. Every source and grant number, and the funder’s role if any.
- Competing interests. Financial and non-financial, for every author. State explicitly if there are none.
- AI use. Any use of generative AI in producing the manuscript, and for what.
- Authorship. That every listed author meets the authorship conditions and has approved the submitted version.
04 · Route
Where to submit
ManuscriptZone is the route to use. The other two exist so that a manuscript is never blocked by a portal: the simple form takes a submission without an account, and the editorial office will take one by email and enter it for you.
- Primary route
- ManuscriptZone — full tracking and direct reviewer correspondence.
- Alternative route
- Simple manuscript submission form — no account required.
- Assisted route
- [email protected] — the editorial office will enter the submission on your behalf.
Authors must use only one submission route for the same manuscript. Submitting the same work by more than one route creates duplicate records and delays it.
05 · After
What happens next
Screening
All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Screening covers scope, completeness of reporting, the declarations above, and similarity.
Assignment
A handling editor is assigned by subject rather than by rota. An editor with an interest in the manuscript takes no part in it.
Peer review
Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
Decision
Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal. Reviewers advise; the decision is the editor’s. You will receive the reviewers’ comments with it.
Revision
Respond to each point, and mark the changes. A revision is normally returned to the same reviewers.
Acceptance and production
On acceptance the article processing charge is raised, and production begins: copy-editing, typesetting, proof, DOI registration and publication under CC BY 4.0.
Editorial and production periods are managed as targets that reflect the manuscript and reviewer availability. The editorial office provides a current status on request.
Preparing for double-blind review
For double-blind review, remove author names, affiliations, acknowledgments, funding details, institution names, and other identifying information from the reviewer manuscript. Provide identifying information separately in the title-page file or submission form.
Clinical trial registration
Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.
Where to go next
Before you submit
The full manuscript requirements, the charge and the policies that apply.
Journal of Thyroid Cancer (JTC) · ISSN 2574-4496 · Crossref DOI prefix 10.14302 · published open access by Open Access Pub under CC BY 4.0, with copyright retained by authors. Editorial decisions are independent of any fee, service, membership or role.